Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3199446 | Journal of Allergy and Clinical Immunology | 2011 | 17 Pages |
Abstract
Anti-IL-13 had specific pharmacodynamic action in this nasal allergen challenge model, causing profound inhibition of nasal lining fluid IL-13 responses. In addition, there was a possible effect of anti-IL-13 treatment on total nasal symptom scores in a subgroup with high late-phase nasal IL-13 levels at screening.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Grant C. BSc, Harsha H. MBBS, PhD, Andrew J. MSc, Jens M. MD, Deborah MD, Christoph PhD, David MD, John PhD, Stipo PhD, Onn Min MD, Peter J. FMedSci, FRS, Norbert MD, Trevor T. MBBCh, PhD,